German investment banks and lawyers are frustrated at the latest intervention by the European Parliament to broaden the scope for "poison pill" defence tactics available to companies in the EU that are subject to a takeover bid.
Poison pill tactics include defensive measures such as selling off assets or divestitures of subsidiaries, both of which are designed to make the target less attractive.
